Skip to content
New Weight & Longevity
Microdosing Tirzepatide
Person standing near gym weights, overlaid with icons for low-dose GLP-1 support, quieting food noise and cravings, and supporting healthy inflammatory balance
Microdosing Tirzepatide

Microdosing Tirzepatide Rx

A low-dose GLP-1 approach designed to work in sync with the body, which may help minimize side effects, quiet cravings, and support moderate weight loss.

Starting at
$159 / mo
    • Monthly, 2-mo, and 4-mo plans
    • Starting price applies to 4-mo plans
    • US-licensed pharmacies
    • Pause or cancel anytime
Get Started
80% of users noticed moderate weight loss⁴
Dual GIP + GLP-1 support for appetite and food noise¹ ²
May ease inflammation independent of weight loss³
HSA / FSA
Ongoing, expert support
Free, discreet shipping
100% online
Frequently asked questions
How do you microdose with Tirzepatide?

Microdosing Tirzepatide uses lower amounts than standard dosing. Your provider will guide your plan and help you understand how to measure your dose correctly. The goal is the lowest dose that may deliver a noticeable effect while minimizing side effects.

Can I transition from Microdosing to a regular dose if needed?

Yes. If your goals change or you need more support, your provider can help determine whether a full-dose GLP-1 prescription may be a better fit.

Is Microdosing Tirzepatide a full-dose GLP-1?

No. Microdosing Tirzepatide uses lower amounts than standard GLP-1 dosing and is designed for adults seeking a gentler, clinician-guided approach.

Usage instructions

Microdosing Tirzepatide is self-administered according to your provider-guided titration schedule. If prescribed, a US-licensed provider will provide a tailored dosage schedule and specific treatment instructions with your care plan.

View all FAQs
Important safety information and common side effects

Microdosing Tirzepatide medication may include glycine, an amino acid intended to support cellular function and metabolism. Microdosing Tirzepatide should be used with a reduced-calorie meal plan and increased physical activity.

Do not use with other GLP-1 receptor agonist medications, or any other products containing GLP-1s.

Side effects

Microdosing Tirzepatide is a low-dose injectable GLP-1 (Tirzepatide) prescription.

The most common side effects of Tirzepatide-based medications are nausea and constipation. Other gastrointestinal issues like indigestion, vomiting, and diarrhea may occur, though they are less common. The side effects you may experience will vary depending on your prescribed dose, your medical history, and your lifestyle choices.

Common side effects normally go away on their own within a few days or up to 2-3 weeks. Read our blog for more tips on how to manage GLP-1 side effects. If you find that any side effects persist for longer than this or get worse over time, stop taking your medication and contact your provider as soon as possible.

For a full list of side effects, please review the Mayo Clinic’s Tirzepatide resources.

Potential drug interactions

Tirzepatide may make oral contraceptives less effective. If you’re taking an oral contraceptive, ask your provider about potential alternatives before starting Microdosing Tirzepatide, or switch to a non-oral contraceptive.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin.

Other important safety information

Do not use GLP-1s if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis. Do not use GLP-1s if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed.

Though rare, allergic reactions to GLP-1 medications are possible. If you notice any shortness of breath or swelling around your face, tongue, or throat after using GLP-1s, stop using the medication immediately and contact emergency services right away.

As with any prescription medicine, the dose prescribed is for you and you alone. Do not, under any circumstances, allow anyone else to use your prescription.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Microdosing Tirzepatide is appropriate for you.

Disclaimer

Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Actual product packaging may appear differently than shown.

What is Microdosing Tirzepatide?

(tir-ZEP-uh-tide)

Some people do not need the most aggressive GLP-1 option. They need help getting unstuck. Microdosing Tirzepatide uses lower amounts than standard dosing, potentially supporting moderate weight loss for those dealing with stubborn weight, plateaus, or food noise.1 2

Unlike single-pathway GLP-1s, Tirzepatide works on two pathways at once: GIP and GLP-1. If GLP-1 acts like headphones that help muffle cravings, Tirzepatide’s added GIP pathway may work more like noise cancellation, helping turn down the food-noise in the background.2

Get Started

80% notice weight loss4

80%
Actual results may vary. Data was self-reported by 972 surveyed customers who checked in with their provider on their second and third check-in between 11/1/2025-7/17/2026. All respondents are AgelessRx Microdosing customers who were approved for a prescription after completing an assessment with a medical provider.

How Microdosing Tirzepatide works

Disclaimer

Actual results may vary. Data was self-reported by 972 surveyed customers who checked in with their provider on their second and third check-in between 11/1/2025-7/17/2026. All respondents are AgelessRx Microdosing Tirzepatide customers who were approved for a prescription after completing an assessment with a medical provider.

Our GLP-1 research is shaping what comes next

Most GLP-1 care focuses on doing more. We’re studying what happens when the goal is finding the right amount. With a fully in-house care team, longevity researchers, and 40+ science-backed protocols, we’re built to support the bigger picture of your health.
One of the first longevity-focused clinical trials on GLP-1 microdosing
Stanford PhD-led Research Team behind 11+ longevity clinical trials and 9 peer-reviewed publications
Fully in-house medical team with 199+ years of combined clinical experience
Read our Research

Read our clinical trials

Microdosing GLP-1 and Longevity

AgelessRx researchers are studying GLP-1 microdosing through a longevity-focused lens, exploring how lower-dose protocols may be used in longevity care beyond weight loss.
Read our Research
Subscribe & save

GLP-1 care that starts with you

One-size-fits-all is one-size-fits-none. You deserve a plan that meets you where you are, and gets you to where you want to be.

$159/month

Applies to 4-month plan billed in full

What’s included

  • Personalized, clinician-guided plan
  • Monthly, 2-month, and 4-month plans
  • Dispensed by US-licensed compounding pharmacy
  • Unlimited protocol adjustments and messaging
  • Ongoing support and check-ins
  • Pause or cancel anytime
  • Backed by our in-house Stanford PhD-led team
Get Started

Personalized for you

Made for your biology

No two people age the same way, so no two treatments are exactly the same. Your plan is guided by your symptoms, your biology, and your priorities. It’s a whole “you” approach to living a better, longer life.
Get Started

Clinically studied

The science of Microdosing Tirzepatide

Tirzepatide is the first dual GIP and GLP-1 receptor agonist, acting on receptors in the brain, gut, and fat tissue, influencing appetite, blood sugar, and how the body handles fat.1 3 4

Recent studies have begun exploring lower doses for gentler, broader weight support.2 In studies, Tirzepatide supported a favorable shift in body composition and more fat loss with preserved lean mass, while modulating inflammatory pathways and supporting cardiovascular health.1 3 5
Learn More
How it works

Choosing how you age starts here

Disclaimer

The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. See above for important safety information. Benefits outlined on AgelessRx.com are based on 3rd party studies. Medication is offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown.

Microdosing Tirzepatide educational content medically reviewed by our experts

Dr. Jenell Decker, MD

Medical Director

Trusted expert in preventative care, integrative medicine, and longevity driven clinical practice.
Marshall University Joan C. Edwards School of Medicine
East Carolina University
Concord University

Frequently asked questions

01 How does Microdosing Tirzepatide work?

Tirzepatide works on two pathways, GIP and GLP-1, that are involved in appetite, fullness, and metabolic response.¹ ² Microdosing uses lower amounts than standard dosing, with provider-guided adjustments over time aimed at the lowest dose that helps you hit your goals while minimizing side effects.

02 Can GLP-1 microdosing help with inflammation, not just weight?

This is one of the more genuinely exciting parts of the GLP-1 story. Research shows GLP-1 receptor agonists lower CRP, a key inflammation marker, through mechanisms that go beyond weight loss alone.⁵ In clinical studies, Tirzepatide has been shown to reduce CRP, IL-6, and other inflammatory markers independent of weight loss.³ ⁵ Most of this evidence comes from standard weight loss doses, but the underlying biology and real-world data is a reasonable basis for interest in a lower-dose approach.

03 Will I lose as much weight as a full-dose GLP-1?

Microdosing is not designed to match full-dose GLP-1 weight loss. Full-dose GLP-1s are dosed to maximize weight loss; Microdosing is dosed to find the minimum amount that may deliver metabolic and craving-related benefits while minimizing side effects.

In our own user data, average weight loss by 6 months has been around 10 lbs.

04 How is Microdosing Tirzepatide different from a single-pathway GLP-1?

Most GLP-1 medications work on one pathway. Tirzepatide works on two, GIP and GLP-1, that may help influence appetite, fullness, blood sugar, and how the body handles fat.²

05 How often do I take Microdosing Tirzepatide?

Microdosing Tirzepatide is taken once weekly by subcutaneous injection, only as prescribed by your provider. If approved, you will receive a personalized dosing schedule from your provider based on your unique health history.

Ready to start?

Answer a few questions and take your first step to living well.
Get Started

Have more questions?

We’re here to help you get where you need to be.
Talk to an Expert